O	0	14	Intraoperative	Intraoperative	JJ	B-NP
O	15	23	handling	handling	NN	I-NP
O	24	27	and	and	CC	I-NP
B-Pathological_formation	28	33	wound	wound	NN	I-NP
O	34	41	healing	healing	NN	I-NP
O	42	44	of	of	IN	B-PP
O	45	57	arthroscopic	arthroscopic	JJ	B-NP
O	58	64	portal	portal	JJ	I-NP
B-Pathological_formation	65	71	wounds	wound	NNS	I-NP
O	71	72	:	:	:	O
O	73	74	a	a	DT	B-NP
O	75	83	clinical	clinical	JJ	I-NP
O	84	89	study	study	NN	I-NP
O	90	99	comparing	compare	VBG	B-VP
O	100	105	nylon	nylon	NN	B-NP
O	106	112	suture	suture	NN	I-NP
O	113	117	with	with	IN	B-PP
B-Pathological_formation	118	123	wound	wound	NN	B-NP
O	124	131	closure	closure	NN	I-NP
O	132	138	strips	strip	NNS	I-NP
O	138	139	.	.	.	O

O	140	144	This	This	DT	B-NP
O	145	156	prospective	prospective	JJ	I-NP
O	156	157	,	,	,	I-NP
O	158	164	single	single	JJ	I-NP
O	164	165	-	-	HYPH	I-NP
O	165	171	centre	centre	NN	I-NP
O	172	177	study	study	NN	I-NP
O	178	186	compared	compare	VBD	B-VP
B-Pathological_formation	187	192	wound	wound	JJ	B-NP
O	193	200	closure	closure	NN	I-NP
O	201	208	methods	method	NNS	I-NP
O	209	211	in	in	IN	B-PP
O	212	220	patients	patient	NNS	B-NP
O	221	231	undergoing	undergo	VBG	B-VP
O	232	243	arthroscopy	arthroscopy	NN	B-NP
O	243	244	.	.	.	O

O	245	252	Closure	Closure	NN	B-NP
O	253	255	of	of	IN	B-PP
O	256	268	arthroscopic	arthroscopic	JJ	B-NP
O	269	275	portal	portal	JJ	I-NP
B-Pathological_formation	276	282	wounds	wound	NNS	I-NP
O	283	287	with	with	IN	B-PP
O	288	295	sterile	sterile	JJ	B-NP
O	296	304	adhesive	adhesive	JJ	I-NP
O	305	311	strips	strip	NNS	I-NP
O	312	314	is	be	VBZ	B-VP
O	315	324	effective	effective	JJ	B-ADJP
O	325	328	and	and	CC	O
O	329	339	convenient	convenient	JJ	B-ADJP
O	340	343	for	for	IN	B-PP
B-Pathological_formation	344	349	wound	wound	JJ	B-NP
O	350	360	management	management	NN	I-NP
O	360	361	.	.	.	O

O	362	365	The	The	DT	B-NP
O	366	372	method	method	NN	I-NP
O	373	376	was	be	VBD	B-VP
O	377	387	associated	associate	VBN	I-VP
O	388	392	with	with	IN	B-PP
O	393	394	a	a	DT	B-NP
O	395	402	reduced	reduce	VBN	I-NP
O	403	412	potential	potential	NN	I-NP
O	413	416	for	for	IN	B-PP
O	417	426	infection	infection	NN	B-NP
O	426	427	,	,	,	O
O	428	434	faster	fast	JJR	B-NP
O	435	442	renewal	renewal	NN	I-NP
O	443	445	of	of	IN	B-PP
O	446	453	tensile	tensile	NN	B-NP
O	454	462	strength	strength	NN	I-NP
O	462	463	,	,	,	O
O	464	471	greater	great	JJR	B-NP
O	472	476	cost	cost	NN	I-NP
O	477	490	effectiveness	effectiveness	NN	I-NP
O	490	491	,	,	,	O
O	492	495	and	and	CC	O
O	496	502	better	good	JJR	B-NP
O	503	511	cosmetic	cosmetic	JJ	I-NP
O	512	519	effects	effect	NNS	I-NP
O	520	529	comparing	compare	VBG	B-VP
O	530	534	with	with	IN	B-PP
O	535	541	suture	suture	JJ	B-NP
O	542	549	closure	closure	NN	I-NP
O	549	550	.	.	.	O

O	551	555	This	This	DT	B-NP
O	556	562	method	method	NN	I-NP
O	563	565	of	of	IN	B-PP
B-Pathological_formation	566	571	wound	wound	NN	B-NP
O	572	579	closure	closure	NN	I-NP
O	580	583	may	may	MD	B-VP
O	584	588	also	also	RB	I-VP
O	589	595	reduce	reduce	VB	I-VP
O	596	599	the	the	DT	B-NP
O	600	609	incidence	incidence	NN	I-NP
O	610	612	of	of	IN	B-PP
O	613	619	needle	needle	NN	B-NP
O	620	625	stick	stick	NN	I-NP
O	626	632	injury	injury	NN	I-NP
O	633	635	in	in	IN	B-PP
O	636	639	the	the	DT	B-NP
O	640	647	theatre	theatre	NN	I-NP
O	648	659	environment	environment	NN	I-NP
O	659	660	.	.	.	O

O	661	668	Thereby	Thereby	RB	B-ADVP
O	669	672	the	the	DT	B-NP
O	673	682	incidence	incidence	NN	I-NP
O	683	685	of	of	IN	B-PP
B-Immaterial_anatomical_entity	686	698	percutaneous	percutaneous	JJ	B-NP
O	699	707	exposure	exposure	NN	I-NP
O	708	717	following	follow	VBG	B-PP
O	718	719	a	a	DT	B-NP
O	720	728	surgical	surgical	JJ	I-NP
O	729	738	procedure	procedure	NN	I-NP
O	739	742	may	may	MD	B-VP
O	743	746	not	not	RB	I-VP
O	747	757	facilitate	facilitate	VB	I-VP
O	758	770	transmission	transmission	NN	B-NP
O	771	773	of	of	IN	B-PP
B-Organism_substance	774	779	blood	blood	NN	B-NP
O	780	785	borne	borne	JJ	I-NP
O	786	795	pathogens	pathogen	NNS	I-NP
O	796	800	such	such	JJ	B-PP
O	801	803	as	as	IN	I-PP
O	804	809	human	human	JJ	B-NP
O	810	826	immunodeficiency	immunodeficiency	NN	I-NP
O	827	832	virus	virus	NN	I-NP
O	833	834	(	(	(	O
O	834	837	HIV	HIV	NN	B-NP
O	837	838	)	)	)	O
O	838	839	,	,	,	O
O	840	849	hepatitis	hepatitis	NN	B-NP
O	850	851	C	C	NN	I-NP
O	852	857	virus	virus	NN	I-NP
O	858	861	and	and	CC	O
O	862	871	hepatitis	hepatitis	NN	B-NP
O	872	873	B	B	NN	I-NP
O	874	879	virus	virus	NN	I-NP
O	879	880	.	.	.	O

O	881	883	As	As	IN	B-PP
O	884	885	a	a	DT	B-NP
O	886	892	result	result	NN	I-NP
O	893	895	it	it	PRP	B-NP
O	896	899	may	may	MD	B-VP
O	900	906	reduce	reduce	VB	I-VP
O	907	917	litigation	litigation	NN	B-NP
O	918	920	in	in	IN	B-PP
O	921	926	today	today	NN	B-NP
O	926	927	'	'	''	B-NP
O	927	928	s	s	NNS	I-NP
O	929	937	changing	change	VBG	B-VP
O	938	948	healthcare	healthcare	NN	B-NP
O	949	956	climate	climate	NN	I-NP
O	956	957	.	.	.	O

